Abeona Therapeutics (ABEO) Announces Updated Data from Gene Therapy Trial for Sanfilippo Syndrome Type A at … – StreetInsider.com
|
Abeona Therapeutics (ABEO) Announces Updated Data from Gene Therapy Trial for Sanfilippo Syndrome Type A at …
StreetInsider.com Abeona Therapeutics Inc. (NASDAQ: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, announced updated data from the ongoing gene therapy clinical trial for … |
